Sumitomo Pharma Rejects Gotham City Research Report

TOKYO, Aug 04 (Pulse News Wire) – Sumitomo Pharma CO.,LTD. (4506.T) confirmed on Thursday that Gotham City Research LLC published a report on the company and its group on August 3, 2026.

The report includes opinions and claims made solely by the author and does not represent the views of Sumitomo Pharma. The company adheres to laws and applicable accounting standards in preparing and disclosing consolidated financial statements and financial statements (hereinafter referred to as "financial statements"). Sumitomo Pharma undergoes audits conducted by certified public accountants based on the Financial Instruments and Exchange Act and the Companies Act, receiving unqualified audit opinions.

As of now, the company has found no evidence supporting the allegations of misrepresentation in the financial statements or inappropriate accounting treatments mentioned in the report. Therefore, there are currently no plans to revise any previously disclosed financial statements. Sumitomo Pharma remains committed to timely and appropriate information disclosure going forward.